Characterisation of the Biochemical Profile and Physiology of the Coronary Circulation in Takotsubo Syndrome
Recruiting
Observational Study
Tako Tsubo Cardiomyopathy
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- A.O.U. Città della Salute e della Scienza · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Consecutive consenting patients over the age of 18 years diagnosed with Takotsubo syndrome according to the position statement of the European Journal of Heart Failure (2016) will be included in the study. The primary endpoint is to evaluate the incidence of coronary microcirculation dysfunction and its correlation with the clinical presentation and the prognosis in patients with TAKO-Tsubo syndro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years;
* Diagnosis of Takotsubo syndrome
* Signing of informed consent
Exclusion Criteria:
* Age \<18 years;
* Refusal to sign written informed consent.
Contacts